Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II)

Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Daniel J. Weisdorf(University of Minnesota), Shahrukh K. Hashmi(King Faisal Specialist Hospital & Research Centre), Amr Nassar(Cairo University), Éliane Gluckman(European Organisation for Rare Diseases), Mohamad Mohty(Sorbonne Université), Douglas Rizzo, Marcelo C. Pasquini, Mehdi Hamadani, Wael Saber, Parameswaran Hari, Mohamed A. Kharfan‐Dabaja(Mayo Clinic in Florida), Navneet S. Majhail(Cleveland Clinic), Usama Gerges(NewYork–Presbyterian Hospital), Amir Ali Hamidieh(Tehran University of Medical Sciences), Fazal Hussain(King Faisal Specialist Hospital & Research Centre), Alaa Elhaddad(Cairo University), H. K. Mahmoud(Cairo University), Abdelghani Tbakhi(King Hussein Cancer Center), Tarek Ben Othman, Rose Marie Hamladji, Mohamed Amine Bekadja(University Hospital of Oran), Parvez Ahmed(Armed Forces Institute of Pathology), Ali Bazarbachi(American University of Beirut Medical Center), S. Adil(King Faisal Specialist Hospital & Research Centre), Salam Alkindi(King Faisal Specialist Hospital & Research Centre), Saleh Ladeb(King Faisal Specialist Hospital & Research Centre), David Dennison(Cairo University), Mahomed Patel(University of the Witwatersrand), Peihua Lu(European Organisation for Rare Diseases), Asmae Quessar(Hôpital 20 Août), Shinichiro Okamoto(King Faisal Specialist Hospital & Research Centre), Yoshiko Atsuta(Keio University), Ayman Alhejazi(King Abdulaziz Medical City), Mouhab Ayas(King Faisal Specialist Hospital & Research Centre), Syed Osman Ahmed(King Faisal Specialist Hospital & Research Centre), N Novitzky(Africa Society for Blood Transfusion), Alok Srivastava(Christian Medical College, Vellore), Adriana Seber(Instituto de Oncologia do Paraná), Hassan El‐Solh(King Faisal Specialist Hospital & Research Centre), Ardeshir Ghavamzadeh(Tehran University of Medical Sciences), Dennis L. Confer(Cairo University), Y Kodera(Sorbonne Université), Hildegard Greinix(Graz University Hospital), Jeff Szer(Cleveland Clinic), Mary M. Horowitz, Dietger Niederwieser(Cairo University)
Hematology/Oncology and Stem Cell Therapy
August 20, 2019
Cited by 33Open Access
Full Text

Abstract

The development of hematopoietic stem cell transplantation (HSCT) programs can face significant challenges in most developing countries because such endeavors must compete with other government health care priorities, including the delivery of basic services. While this is may be a limiting factor, these countries should prioritize development of the needed expertise to offer state of the art treatments including transplantation, by providing financial, technological, legal, ethical and other needed support. This would prove beneficial in providing successful programs customized to the needs of their population, and potentially provide long-term costsavings by circumventing the need for their citizens to seek care abroad. Costs of establishing HSCT program and the costs of the HSCT procedure itself can be substantial barriers in developing countries. Additionally, socioeconomic factors intrinsic to specific countries can influence access to HSCT, patient eligibility for HSCT and timely utilization of HSCT center capabilities. This report describes recommendations from the Worldwide Network for Blood and Marrow Transplantation (WBMT) for establishing HSCT programs with a specific focus on developing countries, and identifies challenges and opportunities for providing this specialized procedure in the resource constrained setting.


Related Papers